Taylor Dispersion Analysis for assessing the self-association and stability of Insulin
July 2, 2015
Using Insulin as a case study, Taylor Dispersion measurements are used to monitor self-association and oligomeric state in a variety of buffer conditions, and have the ability to render surfactants and excipients invisible in measurement data.
1 min read
Architects of Quality
June 29, 2015
Quality by Design: we’ve all heard the phrase – and know we should be fully on board with the philosophy. But how?
1 min read
Amine Alchemy
June 29, 2015
Transforming common chemicals into complex amines is the pharmaceutical equivalent of turning lead to gold
1 min read
Eyes on Expansion
June 29, 2015
A round-up of the latest expansion plans and new facilities as building fever grips the industry
1 min read
Teaching Old Drugs New Tricks
June 29, 2015
Could existing drugs be repurposed as a shortcut to treating Ebola?
1 min read
The Innovation Game
June 29, 2015
Big pharma is turning to outside sources to fill pipelines, but how often are companies backing the wrong horse?
1 min read
Managing Mutations
June 29, 2015
Manufacturers must prove that new drug products are free of cancer-causing impurities
1 min read
Business & Regulation
Facilities & Equipment
Technology & Manufacturing
Regulation & Standards
Business & Trends
Sterility Fears at the NIH
June 29, 2015
How did the NIH get it so wrong – and how can it move on?
1 min read
The Price is Right?
June 29, 2015
Rising drug prices are not helping the industry’s image problem
1 min read
How to be Fast and Flexible
June 26, 2015
The biopharmaceutical sector is rapidly evolving – can your supply chain keep up?
1 min read
What Patients Want
June 26, 2015
Most pharma companies want to become more patient focused. But how? You could start by simply listening more carefully.
1 min read
How Does it Feel?
June 26, 2015
When it comes to topical formulations, I firmly believe that patients care about the way a cream or ointment feels – and that it plays a very important role in compliance.
1 min read
One Framework to Rule them All
June 26, 2015
If regulators worldwide are to make good decisions in the face of complex risk–benefit profiles, a transparent and systematic approach is needed. I believe our ‘universal framework’ could be the answer.
1 min read
Finding Humanity in Science
June 26, 2015
What drives someone to throw aside selfish pursuits to focus on projects with true philanthropic impact? Here, the winners of the 2015 Humanity in Science Award provide their answers.
1 min read
Continuous Progress
June 25, 2015
Resistance is futile – big pharma has spoken and continuous manufacturing will be in commercial use in the near future. But let’s not stop there – now it’s time to explore the full potential of the technology.
1 min read
Countdown to Cures
June 25, 2015
Is pharma keeping up with the latest innovations? US legislators say no, and are looking to a new act to accelerate approvals.
1 min read
Shark Attack
June 25, 2015
Could the unique properties of the shark immune system help us create biologics with more bite?
1 min read
Rebel With a Cause
June 25, 2015
Sitting Down With... Kiran Mazumdar-Shaw, Chairperson and Managing Director of Biocon, India.
1 min read
Extending the boundaries of QbD
June 15, 2015
In this article Paul Davies and Paul Kippax from Malvern Instruments examine how a QbD approach can inform analytical instrumentation design and manufacture, focusing on the benefits for those who go on to use the equipment. Examples from the development of the Mastersizer 3000 particle size analyzer demonstrate the practicalities.
1 min read
